Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director/PDMR Shareholding

1st Apr 2015 16:10

RNS Number : 2280J
GlaxoSmithKline PLC
01 April 2015
 

 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

 

I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares ('ADSs') of GlaxoSmithKline plc ('Company').

 

On 31 March 2015, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £15.66 per Ordinary Share, and notional ADSs at a price of $46.80 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 January 2015 to 31 March 2015:

 

Non Executive Director

Ordinary Shares

No. of ADSs

Sir Christopher Gent

3,991.060

Professor Sir Roy Anderson

458.972

Dr Stephanie Burns

486.201

Stacey Cartwright

339.240

Lynn Elsenhans

1,103.464

Sir Philip Hampton

339.240

Judy Lewent

539.049

Sir Deryck Maughan

1,479.741

Dr Daniel Podolsky

1,109.806

Urs Rohner

339.240

Tom de Swaan

419.061

Jing Ulrich

306.518

Hans Wijers

339.240

The Company and the Non-Executive Directors were informed of these allocations on 1 April 2015.

 

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

 

V A Whyte

Company Secretary

 

1 April 2015

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEFLFBEZFBBBV

Related Shares:

Glaxosmithkline
FTSE 100 Latest
Value8,632.33
Change89.77